National Framework Agreement for the Supply of Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies – North of England
The NHS Commissioning Board (Operating Under the Name of NHS England)
This tender has closed
The submission deadline for this contract has passed. There may be more active supplies tenders from The NHS Commissioning Board (Operating Under the Name of NHS England), and hundreds more across the UK public sector.
Key details
Procurement
- 33600000 Pharmaceutical products
What happened
The NHS Commissioning Board (Operating Under the Name of NHS England) awarded this contract to Qualasept Ltd t/a Bath ASU worth £162,800,000 on 3 May 2021.
Description
NHS National framework agreement for the supply of aseptically prepared cytotoxic medicines and monoclonal antibodies – North of England. Period of framework agreement: 1 April 2021 to 31 March 2022 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for the list of purchasing points.
Awarded suppliers (4)
- Qualasept Ltd t/a Bath ASU
- Baxter Healthcare Ltd
- ITH Pharma
- Quantum Aseptic Services
Contact
Identifiers
Explore related tenders
External ID: ot-ocds-70d2nz-72585c88-33ce-496f-8265-99908a04e0e8 • Added 12 May 2026